Luteinizing hormone

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Menopur
Generic Name
Luteinizing hormone
DrugBank Accession Number
DB14741
Background

Not Available

Type
Biotech
Groups
Approved
Biologic Classification
Protein Based Therapies
Hormones
Protein Chemical Formula
Not Available
Protein Average Weight
Not Available
Sequences
Not Available
Synonyms
  • Gonadotropin, luteinizing hormone
  • LH
  • Luteinising hormone
  • Luteinising hormone (human)
  • Luteinizing gonadotropic hormone
  • Luteinizing hormone
  • Luteotropic hormone
  • Pituitary luteinizing hormone

Pharmacology

Indication

Not Available

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Associated Conditions
Associated Therapies
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Humegon Inj 75 I.U.Luteinizing hormone (75 unit / kit) + Follitropin (75 unit / kit) + Sodium chloride (.9 % / kit)Liquid; Powder, for solutionIntramuscularOrganon Canada Ltd Ltee1993-12-312006-08-17Canada flag
MENOGON 75 IU LIYOFILIZE TOZ ICEREN AMPUL,5 ADETLuteinizing hormone (75 iu) + Follitropin (75 iu)Injection, powder, lyophilized, for solutionIntramuscular; SubcutaneousFERRİNG İLAÇ SAN. VE TİC. LTD. ŞTİ.2020-08-14Not applicableTurkey flag
MenopurLuteinizing hormone (75 [iU]/1) + Follitropin (75 [iU]/1) + Sodium chloride (9 mg/1)SubcutaneousFerring Pharmaceuticals Inc.2004-10-29Not applicableUS flag
MENOPUR 1200 IU MULTI DOZ ICIN SC ENJEKSIYONLUK COZELTI TOZU ICEREN FLAKON VE KULLANIMA HAZIR ENJEKTORDE COZUCU (1 ADET FLAKON + 2 ADET KULLANIMA HAZIR ENJEKTOR)Luteinizing hormone (1200 iu/1ml) + Follitropin (1200 iu/1ml)Injection, powder, lyophilized, for solutionSubcutaneousFERRİNG İLAÇ SAN. VE TİC. LTD. ŞTİ.2020-08-14Not applicableTurkey flag
MENOPUR 150 IU IM VE SC ENJEKSIYON IÇIN TOZ IÇEREN FLAKON, 1 ADETLuteinizing hormone (150 iu) + Follitropin (150 iu)Injection, powder, lyophilized, for solutionIntramuscular; SubcutaneousFERRİNG İLAÇ SAN. VE TİC. LTD. ŞTİ.2020-08-14Not applicableTurkey flag
MENOPUR 150 IU IM VE SC ENJEKSIYON IÇIN TOZ IÇEREN FLAKON, 10 ADETLuteinizing hormone (150 iu) + Follitropin (150 iu)Injection, powder, lyophilized, for solutionIntramuscular; SubcutaneousFERRİNG İLAÇ SAN. VE TİC. LTD. ŞTİ.2020-08-14Not applicableTurkey flag
MENOPUR 150 IU IM VE SC ENJEKSIYON IÇIN TOZ IÇEREN FLAKON, 5 ADETLuteinizing hormone (150 iu) + Follitropin (150 iu)Injection, powder, lyophilized, for solutionIntramuscular; SubcutaneousFERRİNG İLAÇ SAN. VE TİC. LTD. ŞTİ.2020-08-14Not applicableTurkey flag
MENOPUR 600 IU MULTI DOZ ICIN SC ENJEKSIYONLUK COZELTI TOZU ICEREN FLAKON VE KULLANIMA HAZIR ENJEKTORDE COZUCU (1 ADET FLAKON + 1 ADET KULLANIMA HAZIR ENJEKTOR)Luteinizing hormone (600 iu/1ml) + Follitropin (600 iu/1ml)Injection, powder, lyophilized, for solutionSubcutaneousFERRİNG İLAÇ SAN. VE TİC. LTD. ŞTİ.2020-08-14Not applicableTurkey flag
MENOPUR 75 IU IM VE SC ENJEKSIYON ICIN TOZ ICEREN FLAKON, 5 ADETLuteinizing hormone (75 iu) + Follitropin (75 iu)Injection, powder, lyophilized, for solutionIntramuscular; SubcutaneousFERRİNG İLAÇ SAN. VE TİC. LTD. ŞTİ.2020-08-14Not applicableTurkey flag
Pergonal 75 I.U.Luteinizing hormone (75 unit / amp) + Follitropin (75 unit / amp)Powder, for solutionIntramuscularEmd Serono, A Division Of Emd Inc., Canada1979-12-312007-05-07Canada flag

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
Not Available
Kingdom
Organic Compounds
Super Class
Organic Acids
Class
Carboxylic Acids and Derivatives
Sub Class
Amino Acids, Peptides, and Analogues
Direct Parent
Peptides
Alternative Parents
Not Available
Substituents
Not Available
Molecular Framework
Not Available
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
8XA4VN1LH4
CAS number
9002-67-9

References

General References
Not Available
RxNav
6383
Wikipedia
Luteinizing_hormone

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedBasic ScienceControlled Ovarian Stimulation / Infertility1
4CompletedOtherCardiovascular Disease (CVD) / Prostatic Neoplasms1
4CompletedTreatmentIn Vitro Fertilization (IVF) / Infertility1
4CompletedTreatmentPregnant State1
4Not Yet RecruitingTreatmentFemale Infertility1
4TerminatedTreatmentIdiopathic Hypogonadotropic Hypogonadism1
4Unknown StatusTreatmentInfertility1
3Active Not RecruitingTreatmentProstate Cancer1
3CompletedTreatmentHypogonadism1
3CompletedTreatmentInfertility / Ovarian Stimulation1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Liquid; powder, for solutionIntramuscular
Injection, powder, lyophilized, for solutionIntramuscular; Subcutaneous
Injection, powder, lyophilized, for solutionSubcutaneous
Injection, powder, for solutionIntramuscular; Subcutaneous
Powder, for solutionIntramuscular
KitIntramuscular; Subcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on February 27, 2019 23:25 / Updated on June 12, 2020 16:53